Magnera (NYSE:MAGN) vs. UPM-Kymmene (OTCMKTS:UPMKY) Head-To-Head Comparison

UPM-Kymmene (OTCMKTS:UPMKYGet Free Report) and Magnera (NYSE:MAGNGet Free Report) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Volatility & Risk

UPM-Kymmene has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Magnera has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500.

Insider and Institutional Ownership

0.6% of UPM-Kymmene shares are held by institutional investors. Comparatively, 76.9% of Magnera shares are held by institutional investors. 1.0% of UPM-Kymmene shares are held by company insiders. Comparatively, 2.3% of Magnera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares UPM-Kymmene and Magnera’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
UPM-Kymmene 13.76% 12.57% 8.65%
Magnera -6.97% -10.62% -3.97%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for UPM-Kymmene and Magnera, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UPM-Kymmene 0 0 0 0 0.00
Magnera 0 0 1 0 3.00

Magnera has a consensus target price of $24.00, indicating a potential upside of 14.23%. Given Magnera’s stronger consensus rating and higher possible upside, analysts plainly believe Magnera is more favorable than UPM-Kymmene.

Earnings and Valuation

This table compares UPM-Kymmene and Magnera”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
UPM-Kymmene $12.38 billion 1.14 $1.77 billion $2.65 9.98
Magnera $1.31 billion 0.57 -$60.00 million ($18.34) -1.15

UPM-Kymmene has higher revenue and earnings than Magnera. Magnera is trading at a lower price-to-earnings ratio than UPM-Kymmene, indicating that it is currently the more affordable of the two stocks.

Summary

UPM-Kymmene beats Magnera on 8 of the 14 factors compared between the two stocks.

About UPM-Kymmene

(Get Free Report)

UPM-Kymmene Oyj operates in the forest-based bio industry. It operates through UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood, and Other operations segments. The company provides eucalyptus, birch, and softwood pulp grades for tissue, specialty and graphic papers, boards, and packaging; sawn timber for construction, packaging, distribution, joinery, and furniture industries; and wood-based renewable diesel and renewable naphtha for fuel distributors, transportation, and oil and petrochemicals industries. It is also involved in the generation of electricity through hydro, nuclear, and condensing power plants. In addition, the company offers self-adhesive papers and film label stocks for product and information labelling to label printers and brand owners in food, beverage, personal care, pharmaceutical, and retail segments; label papers and release liners, fine papers, and flexible packaging, as well as label and packaging papers production lines for retailers, printers, publishers, distributors, and paper converters; and graphic papers for advertising, magazines, newspapers, and home and office to publishers, cataloguers, retailers, printers, and merchants. Further, it provides plywood and veneer products for construction, vehicle flooring, liquefied natural gas shipbuilding, and other manufacturing industries; wood and wood-based biomass, and forestry services for woodland and forest owners; outdoor products for construction, and granulates for injection molding and extrusion; wood-based lignin products for industrial use and cell culture hydrogel products for biomedical applications; and biomedical products. The company primarily operates in Europe, North America, and Asia. UPM-Kymmene Oyj was founded in 1995 and is headquartered in Helsinki, Finland.

About Magnera

(Get Free Report)

Magnera’s purpose is to better the world with new possibilities made real. By continuously co-creating and innovating with our partners, we develop original material solutions that make a brighter future possible. With a breadth of technologies and a passion for what we create, Magnera’s solutions propel our customers’ goals forward and solve end-users’ problems, every day.

Receive News & Ratings for UPM-Kymmene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UPM-Kymmene and related companies with MarketBeat.com's FREE daily email newsletter.